TrialScope Appoints Richard Aguinaldo As Chief Financial Officer

JERSEY CITY, N.J., Oct. 21, 2014 /PRNewswire/ -- TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that it has appointed Richard Aguinaldo as Chief Financial Officer. Aguinaldo brings more than 20 years of experience in growing companies, and was most recently at Activu Corporation.

"Richard has extensive experience working with cloud-based technology companies, a background that fully aligns with our core product offering," explained TrialScope CEO, Mike Forgash. " His career tells a story of strong financial expertise and consistent performance. I am excited to welcome Richard to our team and anticipate that he will make an immediate impact."

Prior to joining TrialScope, Aguinaldo served as CFO for Activu Corporation, a leading technology provider of innovative video wall visualization and collaborations solutions. Before joining Activu, Aguinaldo was Finance Director at ShoreTel, Inc., a global telecommunications public company with approximately $300 million in annual revenues and nearly 1,000 employees. Previous to ShoreTel, Aguinaldo was the VP, Finance and Controller for M5 Networks, Inc. for eight years, where he was instrumental in growing the company from $3 million to $60 million in annual revenues, before it was acquired by ShoreTel.

"I am excited to join TrialScope's executive team and be part of a growing company and market," stated Aguinaldo. "I appreciate TrialScope's unique value proposition in the complex compliance market and look forward to contributing my experience to help grow the Company."

About TrialScope
TrialScope simplifies the complexities of clinical transparency management. TrialScope is a proven solution that has been implemented successfully and rigorously tested in the most complex environments with solutions that are currently implemented at 12 of the top 30 global clinical trial sponsors, including 6 of the top 10. The company's market-driven solution and expertise enable sponsors to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater compliance. TrialScope technology offers a fully validated SaaS platform hosted in a private cloud.

Contact:  Alyson Kuritz, 908-892-7149, [email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trialscope-appoints-richard-aguinaldo-as-chief-financial-officer-580758795.html

SOURCE TrialScope

Suggested Articles

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.

The deal gives Sarepta exclusive licenses to four CNS targets plus an option to pay a further $42.5 million to add another four targets to the deal.

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.